SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Orchid Pharma

BSE: 524372 01 Jun 2025
Healthcare
₹ 635.55
Orchid Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Orchid Pharma - Share Price & Details

Market Cap
₹3,189
High /Low
1,998 / 604.0
Stock P/E
32.0
Book Value
₹250.0
Dividend Yield
0.0
ROCE
8.02
ROE
₹8.18
Face Value
10.0
PEG Ratio
1.42
EVEBITDA
₹22.0
Debt
175
CMP / FCF
-123.0
Debt to equity
₹0.14
NP Ann
99.7
High price all time
2,680
Piotroski score
₹4.0
Graham Number
332.0
No. Eq. Shares
5.07
Net CF
₹17.5
Net profit
99.7
Price to book value
2.52
Interest Coverage
₹7.57
Low price all time
3.0
Industry PE
33.5
Reserves
₹1,217
Free Cash Flow
₹-131

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and ServicNANANANA4.6330.9
Triochem Products Ltd.,NANANANA0
Orchid Pharma LimitedNANANANA3,18932.0
IOL CHEMICALS & PHARMACEUTICAL5323.0316.25277.81.08258125.5
NOVARTIS INDIA LTD.NANANANA257225.5

Peer Comparison Chart


About Orchid Pharma

Orchid Pharma Limited, with Security Code 524372, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Orchid Pharma Faces Intense Selling Pressure Amid Significant Stock Losses

(30 May 2025)
Orchid Pharma Ltd is experiencing significant selling pressure, marked by a continuous decline in its stock price over the past week and...
Read more →

₹1,001: That's What Analysts Think Orchid Pharma Limited (NSE:ORCHPHARMA) Is Worth After Its Latest Results

(29 May 2025)
A week ago, Orchid Pharma Limited ( NSE:ORCHPHARMA ) came out with a strong set of full-year numbers that could...
Read more →

Orchid Pharma : Familiarisation program for Independent Directors 2024-25

(23 May 2025)
Orchid Pharma Limited Disclosure under Regulation 25 and 46 of SEBI Regulations, 2015 Background Regulation 25 of SEBI Regulations,...
Read more →

Orchid Pharma to settle disputes with DBS Bank

(11 Apr 2025)
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes.
Read more →

Stock market fall: Star Health, Orchid Pharma, Gensol Engineering hit 52-week low; here's why

(26 Mar 2025)
NIFTY50 and SENSEX opened marginally higher, but benchmark indices soon gave up their morning gains to trade lower amid profit booking.
Read more →

Orchid Pharma Limited's (NSE:ORCHPHARMA) 36% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

(16 Mar 2025)
To the annoyance of some shareholders, Orchid Pharma Limited ( NSE:ORCHPHARMA ) shares are down a considerable 36% in...
Read more →